RIGENERAND SRL
RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.Founded in 2009 by Prof. Massimo Dominici and Prof. Pierfranco Conte, as a spin-off resulting from a joint venture between biomedical company RanD and researchers from the University of Modena and Reggio Emilia, Rigenerand owns proprietary technology to develop and produce biomedical tools to empower the ex-vivo phase of stem cells expansion combining the need of high cell yield with innovative biocompatible materials.
RIGENERAND SRL
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2009-01-01
Address:
Medolla, Emilia-Romagna, Italy
Country:
Italy
Website Url:
http://www.rigenerand-biotech.com
Total Employee:
11+
Status:
Active
Contact:
+39053549307
Email Addresses:
[email protected]
Total Funding:
8.7 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS WordPress Grid Shutterstock Django CSRF Contabo Register.IT DNS
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Investors List
Principia SGR
Principia SGR investment in Venture Round - Rigenerand Srl
Official Site Inspections
http://www.rigenerand-biotech.com Semrush global rank: 3.95 M Semrush visits lastest month: 3.14 K
- Host name: 37.208.110.243
- IP address: 37.208.110.243
- Location: Frankfurt am Main Germany
- Latitude: 50.1382
- Longitude: 8.6183
- Timezone: Europe/Berlin
- Postal: 60488
More informations about "Rigenerand Srl" on Search Engine
Rigenerand - Steps Ahead In Cell Technology
Dec 1, 2021 Rigenerand - Steps Ahead In Cell Technology. Rigenerand is developing and producing cGMP products for cell-gene therapy together with tailored 3D culture biomedical devices for diagnostic and therapeutical applications.See details»
ABOUT US - Rigenerand
From laboratory discoveries to novel technological platforms to treat patients. Founded as spin-off of the University of Modena and Reggio Emilia, Rigenerand is a joint venture between RanD, a biomedical company producing bioreactors for liver support and chemo-hyperthermic technology for cancer and researchers of the University of Modena e ...See details»
Rigenerand Srl - Crunchbase Company Profile & Funding
Headquarters Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Founded Date 2009. Founders Pierfranco Conte. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email [email protected]. Phone Number +39053549307. RigeneranD is committed to develop …See details»
Rigenerand srl | LinkedIn
Rigenerand srl | 2,145 followers on LinkedIn. Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl. Originating as a start-up from the University of...See details»
Evotec adds cell therapy manufacturing facility with acquisition of ...
May 30, 2022 Rigenerand is based in Medolla, Italy, approx. 100 km south of Evotec’s Campus Levi-Montalcini in Verona. With their highly specialised team, Rigenerand operates a first-class certified facility that integrates state-of-the-art cGMP production with R&D and QC labs and development labs.See details»
Evotec acquires Rigenerand Srl - 2022-05-30 - Crunchbase
May 30, 2022 Overview. Acquired Organization: Rigenerand Srl RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications. Acquiring Organization: Evotec Evotec is a pharmaceutical and life science company that provides drug discovery and gene therapy solutions. Announced …See details»
Evotec completes acquisition of Rigenerand - labiotech.eu
Jul 5, 2022 Evotec just announced the strategic transaction to buy Rigenerand Srl, with the deal, signed in May 2022, now completed. Based out of Medolla, Italy, the cell technology company working in the field of cGMP manufacturing of cell therapies will operate as Evotec (Modena) Srl going forward. Acquisition finalized.See details»
Evotec completes acquisition of Rigenerand - Evotec
Hamburg, Germany, 05 July 2022: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed.See details»
Evotec Completes Acquisition of Rigenerand | BioSpace
Jul 5, 2022 HAMBURG, GERMANY / ACCESSWIRE / July 5, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed.See details»
CELL FACTORY - Rigenerand
Cell Factory. Rigenerand wants to be a partner to develop and produce cell and gene therapy to address unmet clinical needs in compliance with highest regulatory standards. The cell factory has a wide controlled contamination area (clean room), a quality control laboratory, a GMP-controlled warehouse and a cryogenic room for cell banking.See details»
Evotec to acquire cell technology firm Rigenerand
May 30, 2022 Evotec has entered a definitive agreement for the acquisition of 100% of the capital of Italy-based cell technology firm Rigenerand for $24.7m (€23m). Founded as a spin-off of the University of Modena and Reggio Emilia in 2009, Rigenerand focuses on the cGMP manufacturing of cell therapies.See details»
Rigenerand srl - Biotechnology - Overview, Competitors, and
Founded in 2009. +39 0535 49307. Medolla, Emilia-Romagna. rigenerand-biotech.com. /rigenerand. Technologies. Rigenerand srl information. Acquired by Evotec SE in July 2022, Rigenerand is now operating as Evotec (Moderna) Srl.See details»
Evotec completes acquisition of Rigenerand
Hamburg, Germany, 05 July 2022: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that the strategic transaction to acquire Rigenerand Srl, signed in May 2022, has been completed.See details»
Rigenerand Srl - Contacts, Employees, Board Members, Advisors …
Organization. Rigenerand Srl. Connect to CRM. Save. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 2. About. Rigenerand Srl has 2 current employee profiles, including Co-Founder Pierfranco Conte. Contacts. We're working on getting contact data for Rigenerand Srl.See details»
WEB & NEWS - Rigenerand
Oct 12, 2021 RIGENERAND Srl. Via Maestri del Lavoro, n. 4 41036 Medolla (MO) Italy Tel. +39 0535 187.61.72 Fax +39 0535 187.20.53 C.F. / P.IVA (VAT) 03281630362See details»
RR001 (Rigenerand) Rigenerand S.r.l. - [LSE] Life-Sciences …
Rigenerand SRL is a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for regenerative medicine and oncology and 3D bioreactors as alternative to animal testing for pre-clinical investigations.See details»
Rigenerand Srl - Funding, Financials, Valuation & Investors
Rigenerand Srl is funded by Principia SGR. Which investors participated in the most funding rounds? Show. Unlock even more features with Crunchbase Pro. Start Your Free Trial. RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.See details»
CELL AND GENE THERAPY - Rigenerand
CELL AND GENE THERAPY - Rigenerand. The development of new therapeutic approaches based on manipulated cells represents the new frontier for the treatment of tumors, on the side of conventional pharmacological therapies. …See details»
Rigenerand SRL - DevelopmentAid
Rigenerand SRL — Supplier from Italy, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Laboratory & Measurement sectorsSee details»
Rigenerand Srl - Tech Stack, Apps, Patents & Trademarks
RigeneranD is committed to develop biomedical devices supporting the culture of stem cells for pre-clinical and clinical applications.See details»